Adjuvant Treatment With a Mammalian Target of Rapamycin Inhibitor, Sirolimus, and Steroids Improves Outcomes in Patients With Severe H1N1 Pneumonia and Acute Respiratory Failure*

Overview of attention for article published in Critical Care Medicine, February 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

policy: 3 policy sources
twitter: 15 X users
patent: 7 patents

reddit: 1 Redditor
guideline: 1 clinical guideline source

Readers on

mendeley: 142 Mendeley

So far, Altmetric has seen 20 X posts from 15 X users, with an upper bound of 140,361 followers.

mTOR阻害剤であるラパマイシン（シロリムス)のアジュバント治療は、重度のH1N1インフルエンザウイルス肺炎および急性呼吸不全の患者の転帰を改善する。 https://t.co/9hAEaNhebs

RT @Blagosklonny: It was done but for different reasons. Note: rapamycin is sirolumus In patients with severe H1N1 pneumonia, treatment w…

RT @Blagosklonny: In humans. Sirolimus (#rapamycin) combined with oseltamivir and corticosteroids decreases viral titer and improves respir…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 16 additional X posts.